NCT05278208 2026-04-13Lutathera for Treatment of Recurrent or Progressive High-Grade CNS TumorsNationwide Children's HospitalPhase 1/2 Recruiting65 enrolled
NCT03093116 2026-04-03TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 5 FDA